Tibor Harkany
- Cellular and Molecular Neuroscience top 0.2%
- Pharmacology top 0.1%
- Molecular Biology top 2%
- Physiology top 0.5%
- Cognitive Neuroscience top 1%
- Co-authors
- Ken MackieYuri ZilberterErik KeimpemaJan MulderBotond PenkePaul BerghuisPaul G.M. LuitenAlán Alpár
- Topics
- Neuroscience and Neuropharmacology Research (80 papers)Cannabis and Cannabinoid Research (38 papers)Alzheimer's disease research and treatments (24 papers)
In The Last Decade
Tibor Harkany
171 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cellular and Molecular Neuroscience 4.4k
- Pharmacology 3.1k
- Molecular Biology 2.6k
- Physiology 2.2k
- Cognitive Neuroscience 1.8k
Countries citing papers authored by Tibor Harkany
This map shows the geographic impact of Tibor Harkany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Harkany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Harkany more than expected).
Fields of papers citing papers by Tibor Harkany
This network shows the impact of papers produced by Tibor Harkany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Harkany. The network helps show where Tibor Harkany may publish in the future.
Co-authorship network of co-authors of Tibor Harkany
This figure shows the co-authorship network connecting the top 25 collaborators of Tibor Harkany. A scholar is included among the top collaborators of Tibor Harkany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tibor Harkany. Tibor Harkany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 10 | |
| 6 | 15 | |
| 7 | 5 | |
| 8 | 8 | |
| 9 | 6 | |
| 10 | 102 | |
| 11 | 15 | |
| 12 | 14 | |
| 13 | 64 | |
| 14 | 21 | |
| 15 | 257 | |
| 16 | 64 | |
| 17 | 27 | |
| 18 | 41 | |
| 19 | 78 | |
| 20 | Glucocorticoids and adrenalectomy alter the beta-amyloid induced cell death in rat magnocellular nucleus basalis. | 1 |
About Tibor Harkany
Tibor Harkany is a scholar working on Cellular and Molecular Neuroscience, Developmental Neuroscience and Pharmacology, having authored 176 papers that have together received 9.6k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (80 papers), Cannabis and Cannabinoid Research (38 papers) and Alzheimer's disease research and treatments (24 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (4.4k citations), Pharmacology (3.1k citations) and Developmental Neuroscience (739 citations). Tibor Harkany has collaborated with scholars based in Sweden, Austria and Hungary. Frequent co-authors include Ken Mackie, Yuri Zilberter, Erik Keimpema, Jan Mulder, Botond Penke, Paul Berghuis, Paul G.M. Luiten, Alán Alpár, Manuel Guzmán and Yasmin L. Hurd. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.